Taurine 8 pp 259-267 | Cite as

Taurine Chloramine Administered In Vivo Increases NRF2-Regulated Antioxidant Enzyme Expression in Murine Peritoneal Macrophages

  • In Soon Kang
  • Chaekyun KimEmail author
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 775)


Taurine chloramine (TauCl) is produced from taurine by the ­myeloperoxidase-halide system in activated neutrophils via a stoichiometric reaction between taurine and HOCl. TauCl has been shown to provide cytoprotection against inflammatory tissue injury by inhibiting the overproduction of inflammatory mediators and also by increasing the expression of antioxidant enzymes that are regulated by nuclear factor E2-related factor 2 in murine macrophages. In this study, primary murine macrophages were prepared after either by injection of 3% thioglycolate into mouse peritoneal cavity or by differentiation of the isolated bone marrow cells. TauCl increased HO-1, Prx-1, and Trx-1 expression in murine primary ­macrophages. Also, when TauCl was injected in combination with 3% thioglycolate, HO-1 expression in the peritoneal macrophages was increased. Our results suggest that TauCl plays a protective role against cytotoxicity of oxidative stress in macrophages by increasing the expression of antioxidant enzymes in vivo.


Peritoneal Macrophage Antioxidant Response Element Murine Peritoneal Macrophage Free Heme Antioxidant Enzyme Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Antioxidant response element


Bone marrow-derived macrophages


Glutathione peroxidase


Heme oxygenase


Kelch-like ECH-associated protein




Macrophage colony stimulating factor






Nuclear factor E2-related factor




Taurine chloramine


Tumor necrosis factor-α





We thank Dr. Young-Nam Cha for discussions throughout the study and critical comments on the manuscript, and Mi Ran Cho for the technical support. This work was supported by the NRF of Korea grant funded by the Korea government MEST (2012R1A1A3007097) and Inha University research grant.


  1. Barua M, Liu Y, Quinn MR (2001) Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity. J Immunol 167:2275–2281PubMedGoogle Scholar
  2. Colville-Nash PR, Qureshi SS, Willis D, Willoughby DA (1998) Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J Immunol 161:978–984PubMedGoogle Scholar
  3. Jang JS, Piao SY, Cha Y-N, Kim C (2009) Taurine chloramine activates Nrf2, increases HO-1 expression and protects cells from death caused by hydrogen peroxide. J Clin Biochem Nutr 45:37–43CrossRefGoogle Scholar
  4. Kanayama A, Inoue J, Sugita-Konishi Y, Shimizu M, Miyamoto Y (2002) Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. J Biol Chem 277:24049–24056PubMedCrossRefGoogle Scholar
  5. Kim C, Jang JS, Cho MR, Agarawal SA, Cha Y-N (2010a) Taurine chloramine induces heme ­oxygenase-1 expression via Nrf2 activation in murine macrophages. Int Immunopharmacol 10: 440–446PubMedCrossRefGoogle Scholar
  6. Kim C, Park E, Quinn MR, Schuller-Levis G (1996) The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-alpha in the conditioned media is inhibited by taurine chloramine. Immunopharmacology 34:89–95PubMedCrossRefGoogle Scholar
  7. Kim JW, Kim C (2005) Inhibition of LPS-induced NO production by taurine chloramine in macrophages is mediated though Ras-ERK-NF-kappaB. Biochem Pharmacol 70:1352–1360PubMedCrossRefGoogle Scholar
  8. Kim KS, Choi H-M, Oh DH, Kim C, Jeong JS, Yoo MC, Yang H-I (2010b) Effect of taurine chloramine on the production of matrix metalloproteinases (MMPs) in adiponectin- or IL-1β-stimulated fibroblast-like synoviocytes. J Biomed Sci 17(S1):S27PubMedCrossRefGoogle Scholar
  9. Kim KS, Park EK, Ju SM, Jung HS, Bang JS, Kim C, Lee YA, Hong SJ, Lee SH, Yang HI, Yoo MC (2007) Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes. Arthritis Res Ther 9:R80PubMedCrossRefGoogle Scholar
  10. Kontny E, Szczepanska K, Kowalczewski J, Kurowska M, Janicka I, Marcinkiewicz J, Maslinski W (2000) The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 43: 2169–2177PubMedCrossRefGoogle Scholar
  11. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszynska T (1995) Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol 58:667–674PubMedGoogle Scholar
  12. Marcinkiewicz J, Nowak B, Grabowska A, Bobek M, Petrovska L, Chain B (1999) Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system. Immunology 98:371–378PubMedCrossRefGoogle Scholar
  13. Olszanecki R, Marcinkiewicz J (2004) Taurine chloramine and taurine bromamine induce heme oxygenase-1 in resting and LPS-stimulated J774.2 macrophages. Amino Acids 27:29–35PubMedCrossRefGoogle Scholar
  14. Otterbein LE, Bach FH, Alam J, Soares M, Lu HT, Wysk M, Davis RJ, Flavell RA, Choi AMK (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6:422–428PubMedCrossRefGoogle Scholar
  15. Park E, Schuller-Levis G, Quinn MR (1995) Taurine chloramine inhibits production of nitric oxide and TNF-alpha in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 154:4778–4784PubMedGoogle Scholar
  16. Piao SY, Cha Y-N, Kim C (2011) Taurine chloramine protects RAW 264.7 macrophages from hydrogen peroxide-induced apoptosis by increasing antioxidants. J Clin Biochem Nutr 49:50–56PubMedCrossRefGoogle Scholar
  17. Srisook K, Kim C, Cha Y-N (2005) Cytotoxic and cytoprotective actions of O2 - and NO (ONOO-) are determined both by cellular GSH level and HO activity in macrophages. Methods Enzymol 396:414–424PubMedCrossRefGoogle Scholar
  18. Tenhunen R, Marver HS, Schmid R (1968) The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 61:748–755PubMedCrossRefGoogle Scholar
  19. Thomas EL, Grisham MB, Jefferson MM (1986) Preparation and characterization of chloramines. Methods Enzymol 132:569–585PubMedCrossRefGoogle Scholar
  20. Wang Y, Cha Y-N, Kim KS, Kim C (2011) Taurine chloramine inhibits osteoclastgenesis and lymphocyte proliferation in mice with collagen-induced arthritis. Eur J Pharmacol 668:325–330PubMedCrossRefGoogle Scholar
  21. Yamauchi A, Kim C, Li S, Marchal CC, Towe J, Atkinson SJ, Dinauer MC (2004) Rac2-deficient murine macrophages have selective defects in superoxide production and phagocytosis of opsonized particles. J Immunol 173:5971–5979PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Laboratory for Leukocyte Signaling Research, Department of Pharmacology and Toxicology, Inha Research Institute for Medical ScienceInha University School of MedicineIncheonKorea

Personalised recommendations